All this talk of signing new labs, expanding into existing labs, repeat customer orders, lumpy revenue..... yet $60k sales for the quarter and $90k last quarter. Maybe Andrew should be asked, how many of the existing labs are re-ordering? Have any labs dropped off? Are you running a loss leader so you can say you signed labs? It's not adding up Andrew! Probably time for him to be moved on.
- Forums
- ASX - By Stock
- BCT
- Ann: Open Briefing
Ann: Open Briefing, page-2
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BCT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.616M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
BCT (ASX) Chart |
Day chart unavailable
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online